Pdt Partners, LLC Alx Oncology Holdings Inc Transaction History

Pdt Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$9.51 - $12.95 $139,178 - $189,523	-14,635 Reduced 40.24%	21,735 $244,000
Q3 2022 Nov 14, 2022	SELL	$8.23 - $15.14 $545,862 - $1 Million	-66,326 Reduced 64.58%	36,370 $348,000
Q2 2022 Aug 15, 2022	BUY	$5.89 - $19.46 $604,879 - $2 Million	102,696 New	102,696 $831,000
Q1 2022 May 16, 2022	SELL	$13.65 - $22.06 $206,852 - $334,297	-15,154 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $325,659 - $1.13 Million	15,154 New	15,154 $326,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $52.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.